Literature DB >> 3048977

Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring.

A Glynn-Barnhart1, M Hill, S J Szefler.   

Abstract

Theophylline is an important antiasthmatic medication which has bronchodilator properties. With increased understanding of the relationships of serum theophylline concentration and effect, both adverse and beneficial, oral dosage forms were developed to provide consistent serum theophylline concentrations with the benefit of convenient dosage intervals for long term use. Since factors such as concurrent disease states, drug interactions and age have a profound effect on theophylline disposition, relatively sophisticated dosage guidelines have evolved. Theophylline is in fact a model drug for the application of pharmacokinetic principles to the individualization of a treatment regimen. The purpose of this discussion is to review the relationship of serum theophylline concentration and pharmacodynamic effect and the special properties of oral sustained release theophylline formulations, and to provide a practical approach to prescribing theophylline. Guidelines are provided on the use of serum theophylline concentrations to individualize the theophylline dose, with an analysis of available techniques to monitor theophylline.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048977     DOI: 10.2165/00003495-198835060-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  83 in total

1.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

2.  Pharmacologic effects of intravenously administered aminophylline in asthmatic children.

Authors:  R Maselli; G L Casal; E F Ellis
Journal:  J Pediatr       Date:  1970-05       Impact factor: 4.406

Review 3.  Effects of theophylline on learning and behavior: reason for concern or concern without reason?

Authors:  M Weinberger; S Lindgren; B Bender; J A Lerner; S Szefler
Journal:  J Pediatr       Date:  1987-09       Impact factor: 4.406

4.  Absolute bioavailability of oral theophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am J Hosp Pharm       Date:  1977-05

Review 5.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

6.  A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma.

Authors:  C T Furukawa; G G Shapiro; C W Bierman; M J Kraemer; D J Ward; W E Pierson
Journal:  Pediatrics       Date:  1984-10       Impact factor: 7.124

7.  Nonlinear theophylline elimination.

Authors:  D D Tang-Liu; R L Williams; S Riegelman
Journal:  Clin Pharmacol Ther       Date:  1982-03       Impact factor: 6.875

8.  Pharmacokinetics of theophylline in hepatic disease.

Authors:  A Mangione; T E Imhoff; R V Lee; L Y Shum; W J Jusko
Journal:  Chest       Date:  1978-05       Impact factor: 9.410

9.  Influence of food on the absorption of theophylline from a sustained release formulation (Somophyllin).

Authors:  S Pedersen; J Møller-Petersen
Journal:  Clin Allergy       Date:  1985-05

10.  Food does not effect in bioavailability of theophylline from Theolin Retard.

Authors:  A P Sips; P M Edelbroek; S Kulstad; F A de Wolff; J H Dijkman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more
  2 in total

Review 1.  Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review).

Authors:  Markus Zeitlinger; Markus Müller; Christian Joukhadar
Journal:  AAPS J       Date:  2005-10-22       Impact factor: 4.009

Review 2.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.